EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

A CASE REPORT OF NEONATAL MELIOIDOSIS FROM A TERTIARY CARE HOSPITAL, BANGLADESH.

*Dr. Abu Naser Ibne Sattar and Dr. Sanjida Khondakar Setu

ABSTRACT

Gram-negative environmental bacterium Burkholderia pseudomallei is the aetiological agent of melioidosis. About 89,000 deaths per year worldwide occurs due to this life-threatening infection. Manifestations of melioidosis can range from acute septicaemia to chronic infection. Due to its facultative intracellular survival and virulence factors, B. pseudomallei can manipulate the host's immune responses and signalling pathway to escape immune surveillance. Difficulties in clinical recognition and laboratory diagnosis of melioidosis causes delay in proper antimicrobial therapy. Which often lead to poor outcomes and mortality. For early confirmation of the diseases, better diagnostic tests are needed, which would enable better therapeutic efficacy and survival.

Keywords: Burkholderia pseudomallei, neonatal melioidosis, sepsis, apgar score.

[Full Text Article] [Download Certificate]